Role of Clinical Pharmacology in the Development of Antiplatelet DrugsPATRONO, Carlo.Clinical therapeutics. 2014, Vol 36, Num 12, pp 2096-2111, issn 0149-2918, 16 p.Article

Efficacy and safety of aspirin in the long-term management of atherothrombosisPATRONO, Carlo.Haematologica (Roma). 2001, Vol 86, Num 11, pp 19-21, issn 0390-6078, SUP2Article

Antiplatelet drugsBORN, Gustav; PATRONO, Carlo.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S241-S251, SUP1Article

Aspirin : New cardiovascular uses for an old drugPATRONO, Carlo.The American journal of medicine. 2001, Vol 110, Num 1A, pp 62S-65S, issn 0002-9343Conference Paper

Platelet Activation and AtherothrombosisDAVI, Giovanni; PATRONO, Carlo.The New England journal of medicine. 2007, Vol 357, Num 24, pp 2482-2494, issn 0028-4793, 13 p.Article

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: A reappraisalBAIGENT, Colin; PATRONO, Carlo.Arthritis and rheumatism. 2003, Vol 48, Num 1, pp 12-20, issn 0004-3591, 9 p.Article

Nonsteroidal Anti-Inlfammatory Drugs and the HeartPATRONO, Carlo; BAIGENT, Colin.Circulation (New York, N.Y.). 2014, Vol 129, Num 8, pp 907-916, issn 0009-7322, 10 p.Article

The coxibs, selective inhibitors of cyclooxygenase-2FITZGERALD, Garret A; PATRONO, Carlo.The New England journal of medicine. 2001, Vol 345, Num 6, pp 433-442, issn 0028-4793Article

Cyclooxygenase-2 expression and inhibition in atherothrombosisCIPOLLONE, Francesco; ROCCA, Bianca; PATRONO, Carlo et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 2, pp 246-255, issn 1079-5642, 10 p.Article

Nutraceuticals in Diabetes and Metabolic SyndromeDAVI, Giovanni; SANTILLI, Francesca; PATRONO, Carlo et al.Cardiovascular therapeutics (Print). 2010, Vol 28, Num 4, pp 216-226, issn 1755-5914, 11 p.Article

Renal eicosanoidsDUNN, Michael J; PATRONO, Carlo; CINOTTI, Giulio A et al.Advances in experimental medicine and biology. 1989, Vol 259, issn 0065-2598, 438 p.Serial Issue

Antiplatelet AgentsGRESELE, Paolo; BORN, Gustav V.R; PATRONO, Carlo et al.Handbook of experimental pharmacology. 2012, Vol 210, issn 0171-2004, 625 p.Serial Issue

Low-dose aspirin for the prevention ofatherothrombosisPATRONO, Carlo; GARCIA RODRIGUEZ, Luis A; LANDOLFI, Raffaele et al.The New England journal of medicine. 2005, Vol 353, Num 22, pp 2373-2383, issn 0028-4793, 11 p.Article

Intracellular Signaling as a Potential Target for Antiplatelet TherapyANDRE, Patrick.Handbook of experimental pharmacology. 2012, Vol 210, pp 339-367, issn 0171-2004, 29 p.Article

Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera : Current insights and rationale for future studiesLANDOLFI, Raffaele; DI GENNARO, Leonardo; NOVARESE, Linda et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 3, pp 251-259, issn 0094-6176, 9 p.Article

Platelets in Atherosclerosis and ThrombosisSCHULZ, Christian; MASSBERG, Steffen.Handbook of experimental pharmacology. 2012, Vol 210, pp 111-133, issn 0171-2004, 23 p.Article

The Role of Laboratory Monitoring in Antiplatelet TherapyCATTANEO, Marco.Handbook of experimental pharmacology. 2012, Vol 210, pp 471-494, issn 0171-2004, 24 p.Article

Inhibitors of the Interaction Between von Willebrand Factor and Platelet GPIb/IX/VGRESELE, Paolo; MOMI, Stefania.Handbook of experimental pharmacology. 2012, Vol 210, pp 287-309, issn 0171-2004, 23 p.Article

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? meta-analysis of randomised trialsKEARNEY, Patricia M; BAIGENT, Colin; GODWIN, Jon et al.BMJ. British medical journal (International ed.). 2006, Vol 332, Num 7553, pp 1302-1305, issn 0959-8146, 4 p.Article

Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug targetPASCALE, Silvia; PETRUCCI, Giovanna; PATRONO, Carlo et al.Blood. 2012, Vol 119, Num 15, pp 3595-3603, issn 0006-4971, 9 p.Article

Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays : Implications for Aspirin ResistanceSANTILLI, Francesca; ROCCA, Bianca; DAVI, Giovanni et al.Journal of the American College of Cardiology. 2009, Vol 53, Num 8, pp 667-677, issn 0735-1097, 11 p.Article

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphismDRAGANI, Alfredo; FALCO, Angela; SANTILLI, Francesca et al.Thrombosis and haemostasis. 2012, Vol 108, Num 3, pp 533-542, issn 0340-6245, 10 p.Article

Novel Targets for Platelet InhibitionFRESON, Kathleen; VAN GEET, Chris.Handbook of experimental pharmacology. 2012, Vol 210, pp 369-394, issn 0171-2004, 26 p.Article

Antiplatelet Therapy in Peripheral Artery DiseaseVIOLI, Francesco; BASILI, Stefania; BERGER, Jeffrey S et al.Handbook of experimental pharmacology. 2012, Vol 210, pp 547-563, issn 0171-2004, 17 p.Article

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapyDRAGANI, Alfredo; PASCALE, Silvia; CIABATTONI, Giovanni et al.Blood. 2010, Vol 115, Num 5, pp 1054-1061, issn 0006-4971, 8 p.Article